Studies on the synthesis and characterization of four trans- planaramineplatinum(II) complexes of the form trans-PtL(NH3)CL 2 where L = 2-hydroxypyridine, 3-hydroxypyridine, imidazole, and imidazo(1,2-α)pyridine

European Journal of Medicinal Chemistry

Volumn 39, Issue 8, 2004, Pages 691-697

  Huq, Fazlul ^a   Daghriri, Hassan ^a   Yu, Jun Qing ^a   Beale, Philip ^b   Fisher, Keith ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

2 Hydroxypyridine; 3 Hydroxypyridine; Anticancer activity; Cisplatin; Imidazole; Transplatin

Indexed keywords

AMINE(2 HYDROXYPYRIDINE)DICHLOROPLATINUM; AMINE(3 HYDROXYPYRIDINE)DICHLOROPLATINUM; AMINE(IMIDAZOLE)DICHLOROPLATINUM; AMINE[IMIDAZO(1,2 ALPHA)PYRIDINATO]DICHLOROPLATINUM; CISPLATIN; PLATINUM COMPLEX; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG ACTIVITY; HUMAN; HUMAN CELL; OVARY CANCER; OVARY CELL CULTURE; SYNTHESIS;

CELL LINE, TUMOR; HUMANS; IMIDAZOLES; MAGNETIC RESONANCE SPECTROSCOPY; ORGANOPLATINUM COMPOUNDS; PYRIDINES; PYRIDONES; SPECTRUM ANALYSIS, RAMAN; THYMINE;

EID: 3242747549     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejmech.2004.04.005     Document Type: Article

References (15)

1. Pinedo H.M., Schornagel J.H. Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy. 2:1996;Plenum Press, New York
2. Loehrer P.J., Einhorn L.H. Ann. Intern. Med. 100:1984;704-713
3. Dorr R.T., Fritz W.L. Cancer Chemotherapy Handbook. 1980;Kimpton, London
4. Calvert A.H., Newell D.R., Tilby M.J. Oxford Textbook of Oncology. 1995;Oxford University Press, Oxford, New York
5. Daugaard G.A., Abildgaard U. Chemother. Pharmacol. 25:1989;1-9
6. Moroso M.J., Blair R.L. J. Otolaryngol. 12:1983;365-369
7. Cubeddu L.X., Hoffmann I.S., Fuenmayor N.T., Finn A.L. New Engl. J. Med. 322:1990;810-816
8. Gelasco A., Lippard S. Metallopharmaceuticals I: DNA Interactions. 1999;Springer, Berlin, London
9. Farrell N. Met. Ions Biol. Syst. 32:1996;603-639
10. Natile G., Coluccia M. Metallopharmecuticals I: DNA Interactions. 1999;Springer, Berlin, London
11. Levi F., Perpoint B., Focan C., Chollet P., Depres-Brummer P., Zidani R., Brienza S., Itzhaki M., Iacobelli S., et al. Eur. J. Cancer. 29A:1993;1280-1284
12. Farrel N., Kelland L.R., Roberts J.D., Van Beusichem M. Cancer Res. 52:1992;5065-5072
13. Kauffman G., Cowan D. Inorg. Synth. 7:1963;239-245
14. Dhara S. Indian J. Chem. 8:1970;193-194
15. Mosmann T. J. Immunol. Methods. 65:1983;55-63